DUBLIN, Aug 14, 2018 /PRNewswire/ --
The "Drug Discovery Outsourcing Market Analysis Report By Workflow (Lead Identification & Candidate Optimization, Preclinical Development), By Therapeutic Area, By Drug Type, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR
Urging need to identify potential drug candidates for various chronic diseases is anticipated to fuel growth.
Technological advances in in silico drug designing and accelerating integration of Artificial Intelligence (AI) in drug discovery are driving industry progress. Multiple applications of AI algorithms in drug design and discovery provide opportunities for players to offer specialized drug discovery services. It is useful for processes such as target and compound selection, predictive analytics, screening, and drug repurposing.
Projected rise in adoption of outsourcing over the forecast period is expected to boost market revenue generation. Half of the drug discovery processes are anticipated to be outsourced, thereby creating massive opportunities for CROs, CMOs, and CDMOs to expand their market presence.
Number of collaborations among these organizations, key pharmaceutical players, and several universities has increased over the past few years. This rise in alliance further supports the projected increase in growth potential.
High cost and high risk of drug failure are major challenges faced in drug discovery. However, advances in technology that increase efficiency of drug discovery, coupled with increased adoption of highly advanced technology to provide specialized services, allow outsourcing companies to overcome these challenges.
Further key findings from the report suggest:
- Escalating incidence of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is projected to indirectly propel market growth. Advancements in technologies, such as emergence of Artificial Intelligence (AI) in the pharmaceutical industry, is also anticipated to accelerate industry progress
- Moreover, increasing incidences of antibiotic resistance as well as drug resistance have improved focus on discovery of novel compounds to treat conditions such as Multidrug-Resistant TB (MDR-TB)
- Based on workflow, lead identification and candidate optimization is slated for impressive growth owing to high bottlenecks in this workflow segment
- By therapeutic area, oncology drug discovery outsourcing is fueled by increasing demand for oncology solutions, coupled with expanding government support in cancer research
- North America dominates the global market owing to high focus on R&D in identification of novel drug candidates, along with presence of key players
- Asia Pacific is projected to witness the fastest growth over the forecast period as a result of increasing number of CRO, CMOs, and CDMOs in emerging countries. Rising trend of outsourcing manufacturing and R&D activities to countries such as China and India will aid growth in the region
- Some of the major players are Charles River; EVOTEC, Laboratory Corporation of America Holdings; GenScript, Merck & Co., Inc.; Jubilant Biosys; Thermo Fisher Scientific, Inc.; Oncodesign; Albany Molecular Research, Inc.; WuXi AppTec; Dalton Pharma Services; Pharmaceutical Product Development, LLC; DiscoverX Corporation; and QIAGEN
- Collaboration of players with key pharmaceutical companies and academics and research centers is observed to increase in recent years.
Key Topics Covered:
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Drug Discovery Outsourcing Market: Variables, Trends & Scope
3.1 Market Segmentation &Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing trends of partnerships in drug discovery research
3.1.1.2 Rising incidence rate of metabolic, genetic and other chronic diseases
3.1.1.3 Technology advancement in drug discovery
3.1.2 Market restraint analysis
3.1.2.1 High cost and high risk of drug failure
3.2 Penetration &Growth Prospect Mapping for Workflow, 2016
3.3 Drug Discovery Outsourcing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis - Porter's
Chapter 4 Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
4.1 Global Drug Discovery Outsourcing Market: Workflow Movement Analysis
4.2 Target Identification & Screening
4.3 Target Validation & Functional Informatics
4.4 Lead Identification & Candidate Optimization
4.5 Preclinical Development
4.6 Other Associated Workflow
Chapter 5 Drug Discovery Outsourcing Market: Therapeutic Area Estimates & Trend Analysis
5.1 Global Drug Discovery Outsourcing Market: Therapeutic Area Movement Analysis
5.2 Respiratory System Disorders
5.3 Pain and Anesthesia
5.4 Oncology Disorders
5.5 Ophthalmology Disorders
5.6 Hematology Disorders
5.7 Cardiovascular Disorders
5.8 Endocrine Disorders
5.9 Gastrointestinal Disorders
5.10 Immunomodulation Disorders
5.11 Anti-Infective
5.12 Central Nervous System Disorders
5.13 Dermatology Disorders
5.14 Genitourinary System Disorders
Chapter 6 Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis
6.1 Global Drug Discovery Outsourcing Market: Drug Type Movement Analysis
6.2 Small Molecules
6.3 Large Molecules
Chapter 7 Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis by Workflow, Therapeutic Area, & Drug Type
Chapter 8 Competitive Landscape
- Albany Molecular Research Inc.
- EVOTEC
- LabCorp
- GenScript
- QuintilesIMS
- Charles River
- Aptuit LLC
- WIL Research
- Domainex
- Selcia Ltd.
- Viva Biotech Ltd.
- WuXi AppTec
- TGS Lifesciences Pvt Ltd.
- Merck & Co., Inc.
- Sigma-Aldrich Co. LLC
- Thermo Fisher Scientific, Inc.
- QIAGEN
- DiscoverX Corporation
- Dalton Pharma Services
- ONCODESIGN
- Jubilant Biosys
For more information about this report visit https://www.researchandmarkets.com/research/7958vz/global_drug?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:http://www.prnewswire.com/news-releases/global-drug-discovery-outsourcing-market-analysis-report-2018-300696846.html
SOURCE Research and Markets
